Payer+Provider's Health System Review
Class-action suit hits federal rule linking immigrant visas, health insurance status
Study links prior authorizations to treatment delays
October 31, 2019
An FDA advisory board voted for a preterm prevention drug to be taken off the market this week.
Read the full post on Forbes - Healthcare